Trend Watch



Friday, September 24, 2010


The mechanism of action of forskohlin does not entail the activation of adrenergic receptors.

Forskohlin is a known blood pressure lowering agent and is used in the management of hypertension, including ocular hypertension that leads to glaucoma.

Preliminary studies in humans have shown that forskohlin increases the contractility of the heart muscle without increasing oxygen consumption and that it is a vasodilator.

Forskohlin has been shown to inhibit platelet aggregation further validating its beneficial cardiovascular effects.

Clinical studies revealed that forskohlin, in the patented ForsLean® composition, in daily doses of 50 mg for 12 weeks, did not cause adverse effects on the systolic/diastolic blood pressure and the pulse rate.

Forskohlin is known to regulate the secretion of insulin, thereby helping to maintain healthy blood sugar levels.

Forskohlin, in the patented ForsLean® composition, had an LD50 greater than 2000 mg/kg and may therefore be considered safe for use by most healthy people.

As with all other supplements, people taking medications for asthma, hypertension, hyperthyroidism and related conditions as well as those suffering from ulcers or low blood pressure conditions should exercise caution and seek medical supervision.

Forslean plus now is available in leading pharmacies in Malaysia.

RSP is RM 108 for 60's.

No comments: